O&G SAQs · Postpartum care — perinatal mental health
Postnatal mental health — structured SAQ (15 marks)
FRANZCOG-format structured SAQ on postnatal depression with a positive item 10: the EPDS interpretation and the immediate risk assessment, a stepped-care management plan with sertraline as the lactation-compatible first-line drug, recurrence prediction and pre-conception planning, and the referral pathway with a verbal safety-net. Per-sub-part marking rubric included.
On this page
Study tools
Target exams
How this SAQ is marked
Twelve SAQs, 180 marks, two 2-hour papers — roughly 15 marks and 20 minutes each. This stem tests whether you can interpret a positive depression screen with a positive self-harm item, assess risk in the same consultation, prescribe safely in a breastfeeding woman, and plan for the future. Write in short labelled points and name the numbers. [1]
Reveal model answer and mark schemeShowHide
(a) EPDS interpretation and immediate risk assessment (4 marks)
A score of 17 with a 2 on item 10 makes this an urgent assessment, not a referral letter. [1]
- The EPDS is a 10-item self-report screen, scored 0 to 3, maximum 30; a score at or above 13 indicates probable major depression and warrants a structured clinical assessment, not a diagnosis on the form.[1]
- Item 10 asks about thoughts of self-harm and is scored and reported separately from the total. A score of 2 is a positive endorsement and must be followed up in this consultation.[2]
- Ask directly, using plain words: whether she has had thoughts of ending her life, whether she has a plan, whether she has access to means, and whether she has thoughts of harming the baby. The risk assessment is not complete without all four.[6]
- Establish protective factors (the baby, support, engagement), past psychiatric history (her anxiety disorder raises recurrence risk), and current function. Do not let her leave without a named plan for review today or tomorrow.[1][6]
(b) Management plan (6 marks)
One mark each for: risk-based disposition; psychological therapy; the first-line drug with dose; the lactation rationale; the bipolar screen before prescribing; and follow-up structure. [1][4]
- Disposition is driven by risk. With a positive item 10 and an active thought, arrange same-day perinatal mental health review and do not rely on a routine appointment. Where risk is controlled, manage in primary care with a perinatal mental health treatment plan.[6]
- Non-pharmacological: guided self-help, structured exercise, sleep hygiene, and evidence-based psychological therapy — cognitive behavioural therapy or interpersonal therapy, supported by the network meta-analysis of non-pharmacological interventions.[7]
- First-line drug: sertraline 50 mg once daily, titrated to effect, usually up to 200 mg daily.[4]
- Rationale in breastfeeding: the mother-infant serum study found sertraline and its metabolite at very low or undetectable levels in the breastfeeding infant, with no reported adverse effects, and sertraline has a low relative infant dose. Continue breastfeeding — the risk of untreated maternal depression to the dyad exceeds the drug risk.[4][5]
- Screen for bipolar disorder before prescribing an SSRI — ask about past hypomanic episodes, because an SSRI in unrecognised bipolar disorder can precipitate mania. A family history of bipolar disorder or puerperal psychosis is a red flag.[6]
- Follow-up within one week to assess response and tolerability, with a clear plan to escalate to combination therapy or specialist care if there is no improvement.[1]
(c) Recurrence prediction and future pregnancy planning (3 marks)
Award a mark for each correct element. [3]
- Her risk factors for recurrence in a future pregnancy include the personal history of anxiety, this postnatal depressive episode, and any incomplete recovery before conception. Untreated or chronic depression recurs more often.[3]
- Counsel that postnatal depression has a real recurrence risk and that early pregnancy is the time to plan, not the postnatal ward. Arrange a pre-conception consultation with perinatal mental health.[6]
- Plan proactive monitoring: EPDS screening in pregnancy and postnatally, early reintroduction of psychological support, and a documented threshold for restarting medication. If she has been on an effective SSRI, continuing it through pregnancy and the postpartum is often safer than stopping and waiting to relapse.[1]
(d) Referral pathway and safety-net advice (2 marks)
One mark for the pathway, one for the verbal safety-net. [6]
- Referral pathway by urgency: same-day perinatal mental health or crisis team contact given the positive item 10; her general practitioner for shared care and a mental health treatment plan; psychological therapy; and peer support. Know your local mother-and-baby unit pathway in case admission is needed.[6]
- Safety-net, in her words and her partner's: "If you ever feel you might hurt yourself, or you cannot cope, you ring this number or go to the emergency department — any hour, day or night." Give the same advice to the partner and document it.[6]
References7ShowHide
- [1]Cox JL, Holden JM, Sagovsky R Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry, 1987.PMID 3651732
- [2]Qiu X, Wu Y, Sun Y, Levis B, et al. Individual participant data meta-analysis to compare EPDS accuracy to detect major depression with and without the self-harm item. Sci Rep, 2023.PMID 36899016
- [3]Ferrari AJ, Miller PA, Shadid J, Herrera AM, et al. The global prevalence of major depressive disorder during the peripartum period: a systematic review and meta-regression. Lancet Psychiatry, 2026.PMID 42070579
- [4]Wisner KL, Perel JM, Blumer J Serum sertraline and N-desmethylsertraline levels in breast-feeding mother-infant pairs. Am J Psychiatry, 1998.PMID 9585724
- [5]Lanza di Scalea T, Wisner KL Antidepressant medication use during breastfeeding. Clin Obstet Gynecol, 2009.PMID 19661763
- [6]Bergink V, Rasgon N, Wisner KL Postpartum Psychosis: Madness, Mania, and Melancholia in Motherhood. Am J Psychiatry, 2016.PMID 27609245
- [7]Zhu Y, Yang W, Li N, Yang J, et al. Comparative Effectiveness of Non-Pharmacological Interventions for Postpartum Depression and Anxiety: A Network Meta-Analysis. Neuropsychiatr Dis Treat, 2025.PMID 41427009